COYA
Price
$4.87
Change
+$0.01 (+0.21%)
Updated
Aug 21 closing price
Capitalization
114.24M
80 days until earnings call
Intraday BUY SELL Signals
GANX
Price
$2.00
Change
+$0.03 (+1.52%)
Updated
Aug 21 closing price
Capitalization
87.51M
87 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

COYA vs GANX

COYA vs GANX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
COYA vs. GANX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COYA is a Hold and GANX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 23, 2026
Stock price -- (COYA: $4.87 vs. GANX: $2.01)
Brand notoriety: COYA and GANX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COYA: 33% vs. GANX: 35%
Market capitalization -- COYA: $114.24M vs. GANX: $87.51M
COYA [@Biotechnology] is valued at $114.24M. GANX’s [@Biotechnology] market capitalization is $87.51M. The market cap for tickers in the [@Biotechnology] industry ranges from $138.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COYA’s FA Score shows that 1 FA rating(s) are green whileGANX’s FA Score has 0 green FA rating(s).

  • COYA’s FA Score: 1 green, 4 red.
  • GANX’s FA Score: 0 green, 5 red.
According to our system of comparison, both COYA and GANX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COYA’s TA Score shows that 5 TA indicator(s) are bullish while GANX’s TA Score has 6 bullish TA indicator(s).

  • COYA’s TA Score: 5 bullish, 4 bearish.
  • GANX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, GANX is a better buy in the short-term than COYA.

Price Growth

COYA (@Biotechnology) experienced а +1.67% price change this week, while GANX (@Biotechnology) price change was -5.42% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.69%. For the same industry, the average monthly price growth was +15.94%, and the average quarterly price growth was +3349.70%.

Reported Earning Dates

COYA is expected to report earnings on Nov 11, 2026.

GANX is expected to report earnings on Nov 18, 2026.

Industries' Descriptions

@Biotechnology (+3.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
COYA($114M) has a higher market cap than GANX($87.5M). COYA YTD gains are higher at: -16.034 vs. GANX (-37.733). GANX has higher annual earnings (EBITDA): -19.6M vs. COYA (-22.5M). COYA has more cash in the bank: 50.7M vs. GANX (16.5M). COYA has higher revenues than GANX: COYA (7.94M) vs GANX (0).
COYAGANXCOYA / GANX
Capitalization114M87.5M130%
EBITDA-22.5M-19.6M115%
Gain YTD-16.034-37.73342%
P/E RatioN/AN/A-
Revenue7.94M0-
Total Cash50.7M16.5M307%
Total DebtN/A672K-
TECHNICAL ANALYSIS
Technical Analysis
COYAGANX
RSI
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
84%
MACD
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 3 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
83%
Advances
ODDS (%)
Bullish Trend 5 days ago
86%
Bullish Trend 11 days ago
82%
Declines
ODDS (%)
Bearish Trend 11 days ago
87%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
COYA
Daily Signal:
Gain/Loss:
GANX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FNPIX50.740.75
+1.50%
ProFunds Financials UltraSector Inv
THOVX55.590.55
+1.00%
Thornburg Global Opportunities R4
PGIAX41.970.18
+0.43%
Putnam Focused Equity A
VNVNX21.420.04
+0.19%
Natixis Vaughan Nelson Mid Cap N
FGTAX33.68N/A
N/A
Fidelity Advisor Mega Cap Stock A

COYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, COYA has been loosely correlated with GANX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if COYA jumps, then GANX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COYA
1D Price
Change %
COYA100%
+0.21%
GANX - COYA
42%
Loosely correlated
+1.26%
KNSA - COYA
42%
Loosely correlated
+0.71%
RCKT - COYA
39%
Loosely correlated
+0.86%
VIR - COYA
38%
Loosely correlated
+6.19%
EDIT - COYA
37%
Loosely correlated
+5.78%
More

GANX and

Correlation & Price change

A.I.dvisor indicates that over the last year, GANX has been loosely correlated with COYA. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if GANX jumps, then COYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GANX
1D Price
Change %
GANX100%
+1.26%
COYA - GANX
42%
Loosely correlated
+0.21%
AXON - GANX
36%
Loosely correlated
+2.20%
VIR - GANX
35%
Loosely correlated
+6.19%
VTGN - GANX
34%
Loosely correlated
+1.20%
HOWL - GANX
34%
Loosely correlated
+102.57%
More